Genomic screening of the general adult population: key concepts for assessing net benefit with systematic evidence reviews

Affiliations

¹ Center for Genomics and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
² 1] Center for Genomics and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [2] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [3] Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [4] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
³ 1] Center for Genomics and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [2] Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [3] Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
⁴ 1] Center for Genomics and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [2] Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Review

Anya E R Prince et al. Genet Med. 2015 Jun.

. 2015 Jun;17(6):441-3.

doi: 10.1038/gim.2014.129. Epub 2014 Sep 18.

¹ Center for Genomics and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
² 1] Center for Genomics and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [2] Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [3] Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [4] Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
³ 1] Center for Genomics and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [2] Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [3] Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
⁴ 1] Center for Genomics and Society, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA [2] Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

No abstract available

References

1. Evans JP, Berg JS, Olshan AF, Magnuson T, Rimer BK. We screen newborns don’t we?: realizing the promise of public health genomics. Genet Med. 2013;15(5):332–4. - PMC - PubMed
1. Berg JS, Amendola LM, Eng C, et al. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med. 2013;15(11):860–7. - PMC - PubMed
1. Jarvik GP, Amendola LM, Berg JS, et al. Return of Genomic Results to Research Participants: The floor, the ceiling, and choices in between. American Journal of Human Genetics. 2014 (forthcoming) - PMC - PubMed
1. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565–74. - PMC - PubMed
1. American College of Medical Genetics and Genomics (ACMG) [last visited June 10, 2014];ACMG Updates Recommendation on “Opt Out” for Genome Sequencing Return of Results. 2014 Apr. at < https://www.acmg.net/docs/Release_ACMGUpdatesRecommendations_final.pdf>.